Government of Canada announces changes to lower drug prices and lay the foundation for National Pharmacare

Health Canada

9 August 2019 - Today, the Government of Canada announced the final amendments to the Patented Medicines Regulations. 

The most significant reforms to the regulations since their introduction in 1987, these amendments will give the Patented Medicine Prices Review Board (PMPRB) the tools to protect Canadians from excessive prices and make patented medicines more affordable.

Millions of Canadians rely on prescription drugs to stay healthy, manage chronic conditions and cure disease—yet they pay some of the highest prices in the world. Last year, more than a million Canadians had to give up essentials like food and heat to afford the medications they need. That's why the Government of Canada is delivering on its commitment to lower drug prices for all Canadians.

Read Health Canada press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada